Contipharma has just developed a new generation of diagnostic test: a major advance in the fight against epidemics!

After malaria, Contipharma is continuing to innovate with the development of a test that combines the sensitivity and specificity of a PCR test with the speed of an antigenic test – a first in the field.
The first application of this major innovation is the development of a test to detect monkeypox, which is severely affecting the DRC and whose Ib strain, more virulent according to the WHO, is now also spreading to Western countries. The WHO is even sounding the alarm about it.